Scarica l'app Stockscreener
18.52
1.77%
0.42
Precedente Chiudi:
$18.10
Aprire:
$18.92
Volume 24 ore:
99,395
Relative Volume:
0.13
Capitalizzazione di mercato:
$608.17M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.30%
1M Prestazione:
-16.88%
6M Prestazione:
+18.15%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$18.02
$19.09
Intervallo di 1 settimana:
$16.81
$19.36
Portata 52W:
$12.33
$24.92
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
650-771-9796
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
18.23 | 608.17M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
560.62 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
240.71 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
145.86 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.87 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
429.65 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
180 Wealth Advisors LLC Buys Shares of 94,178 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
GRAIL's Galleri Cancer Test Shows High Patient Satisfaction, Minimal Anxiety in Landmark Study - StockTitan
Trend Tracker for (GRAL) - Stock Traders Daily
Why a Roth IRA is the ‘holy grail’ retirement account—no matter your income - Yahoo Finance
Douglas Lane & Associates LLC Buys New Shares in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Liquid Biopsy Market Anticipated to Show Positive Growth - openPR
Grail to partner with Premier - LabPulse
Grail kicks off real-world study of multicancer blood test - LabPulse
Grail (NASDAQ:GRAL) Stock Price Down 7.4%Here's What Happened - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Eastern Progress Online
Arden Theatre Company to Present World Premiere of Holy Grail of Memphis - TheaterMania.com
Short Interest in Grail, Inc. (NASDAQ:GRAL) Rises By 11.9% - MarketBeat
Grail (NASDAQ:GRAL) Trading Down 6.7%Should You Sell? - MarketBeat
Golden Grail Beverages Announces Strategic Update on UPDC Beverages Acquisition - GlobeNewswire
Disappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the company - Yahoo Finance
Grail: What Lies Ahead After the Illumina Spin-Off - ETF Trends
Here's Why We're Watching GRAIL's (NASDAQ:GRAL) Cash Burn Situation - Simply Wall St
Stocks Showing Improving Market Leadership: GRAIL Earns 83 RS Rating - Investor's Business Daily
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Eastern Progress Online
Grail (NASDAQ:GRAL) Shares Gap DownHere's What Happened - MarketBeat
How the (GRAL) price action is used to our Advantage - Stock Traders Daily
Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated (ILMN) - Seeking Alpha
Grail (NASDAQ:GRAL) Shares Down 11.1%Time to Sell? - MarketBeat
GRAIL: Biotech Stock Targeting $100B Cancer Market - MSN
GRAIL to Present at J.P. Morgan Healthcare Conference 2024: Early Cancer Detection Pioneer Takes Stage - StockTitan
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Remedies After Illumina/GRAIL– The Thorny Question of Proportionality - PYMNTS.com
Grail Blood Test - KOIN.com
Grail (NASDAQ:GRAL) Sets New 52-Week HighHere's Why - MarketBeat
Grail, Inc. (NASDAQ:GRAL) Short Interest Up 15.9% in November - MarketBeat
Function Health Collaborates With GRAIL to Offer Multi-Cancer Early Detection Test Nationwide - The Eastern Progress Online
Grail: Lack Of Near Term Catalyst, Market Likely To Lose Interest Soon (NASDAQ:GRAL) - Seeking Alpha
Golden Grail Beverages buys US co-packer UPDC Beverages - Yahoo Finance
Golden Grail Beverages to acquire United Product Development Corp. - Food Business News
Golden Grail Beverages Announces the Acquisition of UPDC Beverages - GlobeNewswire
Golden Grail Beverages Expands Portfolio with Strategic Acquisition of Profitable Co-Packing Powerhouse UPDC - StockTitan
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) - The Eastern Progress Online
Liquid Biopsy Market Poised for Substantial Growth (2024-2031) - openPR
Grail (NASDAQ:GRAL) Hits New 52-Week HighTime to Buy? - MarketBeat
GRAIL to Participate in Upcoming Investor Conferences - Kilgore News Herald
New blood test capable of screening for over 50 cancers available in Canada - Mugglehead
Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible - HIT Consultant
Grail, Inc. (NASDAQ:GRAL) Short Interest Update - MarketBeat
GRAIL Awards 115K Shares in Equity Incentives to Attract Top Talent in Latest Hiring Push - StockTitan
Blood test that can screen for 50+ cancers now for sale in Canada, at $2,099 - CBC News
California startup finds early success with experimental blood test to detect many cancers - Martinsville Bulletin
Grail initiated at equal weight by Morgan Stanley - MSN
Grail initiated at equal weight by Morgan Stanley (NASDAQ:GRAL) - Seeking Alpha
Morgan Stanley cautious on GRAIL stock despite $100B market opportunity - Investing.com
Grail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan Stanley - MarketBeat
Grail initiated with an Equal Weight at Morgan Stanley - TipRanks
Grail Inc Azioni (GRAL) Dati Finanziari
Non sono disponibili dati finanziari per Grail Inc (GRAL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):